![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Skalt, Daniela; Moertl, Bernhard; Bergwelt-Baildon, Michael von; Schmidt, Christian; Schoel, Wolfgang; Buecklein, Veit; Weiglein, Tobias; Dreyling, Martin und Berger, Karin
(2022):
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.
In: Hemasphere, Bd. 6, Nr. 7, e736
2021
Moertl, Bernhard 
ORCID: https://orcid.org/0000-0002-8643-4170; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Schmidt, Christian; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Schoel, Wolfgang; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X und Berger, Karin
(2021):
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
In: Clinical Lymphoma Myeloma and Leukemia
ORCID: https://orcid.org/0000-0002-8643-4170; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Schmidt, Christian; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Schoel, Wolfgang; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X und Berger, Karin
(2021):
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.
In: Clinical Lymphoma Myeloma and Leukemia